Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: Boston Biomedica

This article was originally published in The Gray Sheet

Executive Summary

Boston Biomedica: Nets $12.5 mil. from Nov. 5 initial public offering of 1.6 mil. shares of common stock at $8.50 per share. Underwriters Oscar Gruss & Sons and Kaufman Bros. have an overallotment option of 240,000 additional shares. The West Bridgewater, Massachusetts maker of quality control products used with in vitro diagnostic test kits for infectious diseases will use proceeds from the offering for debt repayment, expansion of manufacturing capacity, investment in technology and other "general corporate purposes"...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007034

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel